These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Enhancement of glucose transport by vascular endothelial growth factor in retinal endothelial cells. Sone H; Deo BK; Kumagai AK Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1876-84. PubMed ID: 10845612 [TBL] [Abstract][Full Text] [Related]
4. Fractalkine, a CX3C chemokine, as a mediator of ocular angiogenesis. You JJ; Yang CH; Huang JS; Chen MS; Yang CM Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5290-8. PubMed ID: 17962485 [TBL] [Abstract][Full Text] [Related]
5. HGF/NK4 inhibited VEGF-induced angiogenesis in in vitro cultured endothelial cells and in vivo rabbit model. Nakabayashi M; Morishita R; Nakagami H; Kuba K; Matsumoto K; Nakamura T; Tano Y; Kaneda Y Diabetologia; 2003 Jan; 46(1):115-23. PubMed ID: 12637990 [TBL] [Abstract][Full Text] [Related]
6. Remodeling retinal neovascularization by ALK1 gene transfection in vitro. Li B; Yin W; Hong X; Shi Y; Wang HS; Lin SF; Tang SB Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4553-60. PubMed ID: 18829861 [TBL] [Abstract][Full Text] [Related]
7. Pigment epithelium-derived factor suppresses ischemia-induced retinal neovascularization and VEGF-induced migration and growth. Duh EJ; Yang HS; Suzuma I; Miyagi M; Youngman E; Mori K; Katai M; Yan L; Suzuma K; West K; Davarya S; Tong P; Gehlbach P; Pearlman J; Crabb JW; Aiello LP; Campochiaro PA; Zack DJ Invest Ophthalmol Vis Sci; 2002 Mar; 43(3):821-9. PubMed ID: 11867604 [TBL] [Abstract][Full Text] [Related]
8. Hypoxia and vascular endothelial growth factor stimulate angiogenic integrin expression in bovine retinal microvascular endothelial cells. Suzuma K; Takagi H; Otani A; Honda Y Invest Ophthalmol Vis Sci; 1998 May; 39(6):1028-35. PubMed ID: 9579483 [TBL] [Abstract][Full Text] [Related]
9. Proliferation, migration, and ERK activation in human retinal endothelial cells through A(2B) adenosine receptor stimulation. Grant MB; Davis MI; Caballero S; Feoktistov I; Biaggioni I; Belardinelli L Invest Ophthalmol Vis Sci; 2001 Aug; 42(9):2068-73. PubMed ID: 11481274 [TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. Aiello LP; Avery RL; Arrigg PG; Keyt BA; Jampel HD; Shah ST; Pasquale LR; Thieme H; Iwamoto MA; Park JE N Engl J Med; 1994 Dec; 331(22):1480-7. PubMed ID: 7526212 [TBL] [Abstract][Full Text] [Related]
11. Suppressed expression of tubedown-1 in retinal neovascularization of proliferative diabetic retinopathy. Gendron RL; Good WV; Adams LC; Paradis H Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):3000-7. PubMed ID: 11687548 [TBL] [Abstract][Full Text] [Related]
12. Serum tenascin-C as a potential predictive marker of angiogenesis in non-small cell lung cancer. Ishiwata T; Takahashi K; Shimanuki Y; Ohashi R; Cui R; Takahashi F; Shimizu K; Miura K; Fukuchi Y Anticancer Res; 2005; 25(1B):489-95. PubMed ID: 15816617 [TBL] [Abstract][Full Text] [Related]
13. Altered expression patterns of VEGF receptors in human diabetic retina and in experimental VEGF-induced retinopathy in monkey. Witmer AN; Blaauwgeers HG; Weich HA; Alitalo K; Vrensen GF; Schlingemann RO Invest Ophthalmol Vis Sci; 2002 Mar; 43(3):849-57. PubMed ID: 11867607 [TBL] [Abstract][Full Text] [Related]
15. Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy. Watanabe D; Suzuma K; Matsui S; Kurimoto M; Kiryu J; Kita M; Suzuma I; Ohashi H; Ojima T; Murakami T; Kobayashi T; Masuda S; Nagao M; Yoshimura N; Takagi H N Engl J Med; 2005 Aug; 353(8):782-92. PubMed ID: 16120858 [TBL] [Abstract][Full Text] [Related]
16. Pleiotrophin induces angiogenesis: involvement of the phosphoinositide-3 kinase but not the nitric oxide synthase pathways. Souttou B; Raulais D; Vigny M J Cell Physiol; 2001 Apr; 187(1):59-64. PubMed ID: 11241349 [TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor (VEGF) enhances the expression of receptors and activates mitogen-activated protein (MAP) kinase of dog retinal capillary endothelial cells. Murata M; Kador PF; Sato S J Ocul Pharmacol Ther; 2000 Aug; 16(4):383-91. PubMed ID: 10977134 [TBL] [Abstract][Full Text] [Related]
18. Angiotensin II type 2 receptor inhibits vascular endothelial growth factor-induced migration and in vitro tube formation of human endothelial cells. Benndorf R; Böger RH; Ergün S; Steenpass A; Wieland T Circ Res; 2003 Sep; 93(5):438-47. PubMed ID: 12881481 [TBL] [Abstract][Full Text] [Related]
19. Herbimycin A inhibits angiogenic activity in endothelial cells and reduces neovascularization in a rat model of retinopathy of prematurity. McCollum GW; Rajaratnam VS; Bullard LE; Yang R; Penn JS Exp Eye Res; 2004 May; 78(5):987-95. PubMed ID: 15051479 [TBL] [Abstract][Full Text] [Related]